Prevalence, clinical presentation, and treatment-management of cerebral venous thrombosis associated with spontaneous intracranial hypotension: A combined case-series and systematic literature review approach.

Spontaneous intracranial hypotension anticoagulant therapy cerebral venous thrombosis epidural blood patch isolated cortical vein thrombosis

Journal

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
ISSN: 2385-2011
Titre abrégé: Interv Neuroradiol
Pays: United States
ID NLM: 9602695

Informations de publication

Date de publication:
21 Jul 2024
Historique:
medline: 22 7 2024
pubmed: 22 7 2024
entrez: 22 7 2024
Statut: aheadofprint

Résumé

Cerebral venous thrombosis (CVT) is a rare complication of spontaneous intracranial hypotension (SIH). Therefore, its correct diagnosis and the corresponding optimal treatment-management identification remains challenging. Over the last 10 years, 300 patients received a definite SIH diagnosis at our stroke center. Through thorough review of the database, we identified all patients with SIH-related CVT. In addition, we performed a systematic literature review including all publications on SIH-related CVT. Five out of our 300 SIH patients showed CVT (F/M:2/3, mean age: 51.8 ± 15.7). Through the literature search, 72 additional cases were identified. Overall, the prevalence was 1.3% and main clinical presentations were orthostatic headache, nausea, and vomiting. The CVT was predominantly located at the superior sagittal sinus. Treatment strategies included anticoagulants (ACs) (43%), epidural blood patch (EBP) (19.4%), and combined AC + EBP (33.3%). In our cohort, all but one patient received combined EBP and AC. The mean clinical and radiological follow-up were 2 years and 1.5 years, respectively. Complete clinical recovery was reported in 96% of the cases, whereas 56% showed complete radiological CVT resolution. Among patients without radiological resolution (26.4%), 57% received AC-only, while 43% received combined AC + EBP. Of our five cases, all but one patient received combined AC + EBP. The overall prevalence of SIH-related CVT was 1.3%. AC and combined AC + EBP were the most used treatment-management strategies. CVT resolution was more commonly achieved after the combined strategy. Overall, the rate of complete clinical recovery was 96%.

Sections du résumé

BACKGROUND BACKGROUND
Cerebral venous thrombosis (CVT) is a rare complication of spontaneous intracranial hypotension (SIH). Therefore, its correct diagnosis and the corresponding optimal treatment-management identification remains challenging.
METHODS METHODS
Over the last 10 years, 300 patients received a definite SIH diagnosis at our stroke center. Through thorough review of the database, we identified all patients with SIH-related CVT. In addition, we performed a systematic literature review including all publications on SIH-related CVT.
RESULTS RESULTS
Five out of our 300 SIH patients showed CVT (F/M:2/3, mean age: 51.8 ± 15.7). Through the literature search, 72 additional cases were identified. Overall, the prevalence was 1.3% and main clinical presentations were orthostatic headache, nausea, and vomiting. The CVT was predominantly located at the superior sagittal sinus. Treatment strategies included anticoagulants (ACs) (43%), epidural blood patch (EBP) (19.4%), and combined AC + EBP (33.3%). In our cohort, all but one patient received combined EBP and AC. The mean clinical and radiological follow-up were 2 years and 1.5 years, respectively. Complete clinical recovery was reported in 96% of the cases, whereas 56% showed complete radiological CVT resolution. Among patients without radiological resolution (26.4%), 57% received AC-only, while 43% received combined AC + EBP. Of our five cases, all but one patient received combined AC + EBP.
CONCLUSION CONCLUSIONS
The overall prevalence of SIH-related CVT was 1.3%. AC and combined AC + EBP were the most used treatment-management strategies. CVT resolution was more commonly achieved after the combined strategy. Overall, the rate of complete clinical recovery was 96%.

Identifiants

pubmed: 39034592
doi: 10.1177/15910199241263139
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

15910199241263139

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Gaetano Risi (G)

Neuroradiology Department, Montpellier University Hospital, Gui-de-Chauliac, Montpellier, France.

Anne Ducros (A)

Neurology Department, Montpellier University Hospital, Gui-de-Chauliac, Montpellier, France.

Liesjet van Dokkum (L)

Neuroradiology Department, Montpellier University Hospital, Gui-de-Chauliac, Montpellier, France.

Nicolas Lonjon (N)

Neurosurgery Department, Montpellier University Hospital, Gui de Chauliac, Montpellier, France.

Nicola Marchi (N)

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.

Max Villain (M)

Department of Ophthalmology, Gui de Chauliac Hospital, Montpellier, France.

Vincent Costalat (V)

Neuroradiology Department, Montpellier University Hospital, Gui-de-Chauliac, Montpellier, France.

Federico Cagnazzo (F)

Neuroradiology Department, Montpellier University Hospital, Gui-de-Chauliac, Montpellier, France.

Classifications MeSH